Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Karpinski

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Transplantation|November 30, 2012
Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft lossJulie Ho, Chris Wiebe, David N Rush, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Proteomic-based detection of urine proteins associated with acute renal allograft rejectionStefan Schaub, David Rush, John Wilkins, et al.
Transplantation|July 14, 2010
Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allograftsJulie Ho, David N Rush, Ian W Gibson, et al.
Transplantation|August 31, 2011
Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitisJulie Ho, David N Rush, Martin Karpinski, et al.
Transplantation Direct|August 9, 2016
Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10Julie Ho, Atul Sharma, Rupasri Mandal, et al.
Transplantation|March 21, 2014
Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 monthsJulie Ho, Chris Wiebe, Ian W Gibson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2021
The negative impact of T cell-mediated rejection on renal allograft survival in the modern eraChristie Rampersad, Robert Balshaw, Ian W Gibson, et al.
Clinical Transplantation|March 28, 2024
Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein-Barr virus, cytomegalovirus, and BK polyomavirus post-kidney transplant: A quality assurance initiativeChristie Rampersad, William Kong, Chris Wiebe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2018
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunityChris Wiebe, Vasilis Kosmoliaptsis, Denise Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejectionChris Wiebe, David N Rush, Ian W Gibson, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Transplantation|November 30, 2012
Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft lossJulie Ho, Chris Wiebe, David N Rush, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Proteomic-based detection of urine proteins associated with acute renal allograft rejectionStefan Schaub, David Rush, John Wilkins, et al.
Transplantation|July 14, 2010
Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allograftsJulie Ho, David N Rush, Ian W Gibson, et al.
Transplantation|August 31, 2011
Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitisJulie Ho, David N Rush, Martin Karpinski, et al.
Transplantation Direct|August 9, 2016
Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10Julie Ho, Atul Sharma, Rupasri Mandal, et al.
Transplantation|March 21, 2014
Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 monthsJulie Ho, Chris Wiebe, Ian W Gibson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2021
The negative impact of T cell-mediated rejection on renal allograft survival in the modern eraChristie Rampersad, Robert Balshaw, Ian W Gibson, et al.
Clinical Transplantation|March 28, 2024
Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein-Barr virus, cytomegalovirus, and BK polyomavirus post-kidney transplant: A quality assurance initiativeChristie Rampersad, William Kong, Chris Wiebe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2018
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunityChris Wiebe, Vasilis Kosmoliaptsis, Denise Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2020
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejectionChris Wiebe, David N Rush, Ian W Gibson, et al.
Pageof 5